Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Nat Commun ; 14(1): 6246, 2023 10 06.
Article in English | MEDLINE | ID: mdl-37803016

ABSTRACT

Cancer cachexia is a complex metabolic disorder accounting for ~20% of cancer-related deaths, yet its metabolic landscape remains unexplored. Here, we report a decrease in B vitamin-related liver enzymes as a hallmark of systemic metabolic changes occurring in cancer cachexia. Metabolomics of multiple mouse models highlights cachexia-associated reductions of niacin, vitamin B6, and a glycine-related subset of one-carbon (C1) metabolites in the liver. Integration of proteomics and metabolomics reveals that liver enzymes related to niacin, vitamin B6, and glycine-related C1 enzymes dependent on B vitamins decrease linearly with their associated metabolites, likely reflecting stoichiometric cofactor-enzyme interactions. The decrease of B vitamin-related enzymes is also found to depend on protein abundance and cofactor subtype. These metabolic/proteomic changes and decreased protein malonylation, another cachexia feature identified by protein post-translational modification analysis, are reflected in blood samples from mouse models and gastric cancer patients with cachexia, underscoring the clinical relevance of our findings.


Subject(s)
Niacin , Stomach Neoplasms , Vitamin B Complex , Mice , Animals , Humans , Cachexia/etiology , Cachexia/metabolism , Proteomics , Pyridoxine , Vitamin B 6 , Liver/metabolism , Glycine/metabolism
2.
Oncogene ; 42(16): 1294-1307, 2023 04.
Article in English | MEDLINE | ID: mdl-36879117

ABSTRACT

Oncometabolites, such as D/L-2-hydroxyglutarate (2HG), have directly been implicated in carcinogenesis; however, the underlying molecular mechanisms remain poorly understood. Here, we showed that the levels of the L-enantiomer of 2HG (L2HG) were specifically increased in colorectal cancer (CRC) tissues and cell lines compared with the D-enantiomer of 2HG (D2HG). In addition, L2HG increased the expression of ATF4 and its target genes by activating the mTOR pathway, which subsequently provided amino acids and improved the survival of CRC cells under serum deprivation. Downregulating the expression of L-2-hydroxyglutarate dehydrogenase (L2HGDH) and oxoglutarate dehydrogenase (OGDH) increased L2HG levels in CRC, thereby activating mTOR-ATF4 signaling. Furthermore, L2HGDH overexpression reduced L2HG-mediated mTOR-ATF4 signaling under hypoxia, whereas L2HGDH knockdown promoted tumor growth and amino acid metabolism in vivo. Together, these results indicate that L2HG ameliorates nutritional stress by activating the mTOR-ATF4 axis and thus could be a potential therapeutic target for CRC.


Subject(s)
Colorectal Neoplasms , TOR Serine-Threonine Kinases , Humans , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism , Signal Transduction , Colorectal Neoplasms/pathology , Amino Acids , Activating Transcription Factor 4/genetics , Activating Transcription Factor 4/metabolism , Alcohol Oxidoreductases/metabolism
4.
Oncogene ; 40(2): 408-420, 2021 01.
Article in English | MEDLINE | ID: mdl-33177648

ABSTRACT

Although the Wnt/ß-catenin pathway plays a central role in the carcinogenesis and maintenance of colorectal cancer (CRC), attempts to target the pathway itself have not been very successful. MyD88, an adaptor protein of the TLR/IL-1ß signaling, has been implicated in the integrity of the intestines as well as in their tumorigenesis. In this study, we aimed to clarify the mechanisms by which epithelial MyD88 contributes to intestinal tumor formation and to address whether MyD88 can be a therapeutic target of CRC. Conditional knockout of MyD88 in intestinal epithelial cells (IECs) reduced tumor formation in Apc+/Δ716 mice, accompanied by decreased proliferation and enhanced apoptosis of tumor epithelial cells. Mechanistically, the MyD88 loss caused inactivation of the JNK-mTORC1, NF-κB, and Wnt/ß-catenin pathways in tumor cells. Induction of MyD88 knockout in the intestinal tumor-derived organoids, but not in the normal IEC-derived organoids, induced apoptosis and reduced their growth. Treatment with the MyD88 inhibitor ST2825 also suppressed the growth of the intestinal tumor-derived organoids. Knockdown of MYD88 in human CRC cell lines with mutations in APC or CTNNB1 induced apoptosis and reduced their proliferation as well. These results indicate that MyD88 loss is synthetic lethal with mutational activation of the Wnt/ß-catenin signaling in intestinal tumor epithelial cells. Inhibition of MyD88 signaling can thus be a novel therapeutic strategy for familial adenomatous polyposis (FAP) as well as for colorectal cancer harboring mutations in the Wnt/ß-catenin signaling.


Subject(s)
Intestinal Mucosa/pathology , Intestinal Neoplasms/pathology , Myeloid Differentiation Factor 88/physiology , Synthetic Lethal Mutations , Wnt Proteins/genetics , beta Catenin/genetics , Animals , Apoptosis , Cell Proliferation , Cells, Cultured , Female , Intestinal Mucosa/metabolism , Intestinal Neoplasms/genetics , Intestinal Neoplasms/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout
5.
Cancer Sci ; 110(8): 2520-2528, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31215118

ABSTRACT

Iodothyronine deiodinase 2 (DIO2) converts the prohormone thyroxine (T4) to bioactive T3 in peripheral tissues and thereby regulates local thyroid hormone (TH) levels. Although epidemiologic studies suggest the contribution of TH to the progression of colorectal cancer (CRC), the role of DIO2 in CRC remains elusive. Here we show that Dio2 is highly expressed in intestinal polyps of ApcΔ716 mice, a mouse model of familial adenomatous polyposis and early stage sporadic CRC. Laser capture microdissection and in situ hybridization analysis show almost exclusive expression of Dio2 in the stroma of ApcΔ716 polyps in the proximity of the COX-2-positive areas. Treatment with iopanoic acid, a deiodinase inhibitor, or chemical thyroidectomy suppresses tumor formation in ApcΔ716 mice, accompanied by reduced tumor cell proliferation and angiogenesis. Dio2 expression in ApcΔ716 polyps is strongly suppressed by treatment with the COX-2 inhibitor meloxicam. Analysis of The Cancer Genome Atlas data shows upregulation of DIO2 in CRC clinical samples and a close association of its expression pattern with the stromal component, consistently with almost exclusive expression of DIO2 in the stroma of human CRC as revealed by in situ hybridization. These results indicate essential roles of stromal DIO2 and thyroid hormone signaling in promoting the growth of intestinal tumors.


Subject(s)
Cell Proliferation/physiology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Iodide Peroxidase/metabolism , Adenomatous Polyposis Coli/drug therapy , Adenomatous Polyposis Coli/metabolism , Adenomatous Polyposis Coli/pathology , Animals , Cell Proliferation/drug effects , Colorectal Neoplasms/drug therapy , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Disease Models, Animal , Humans , Intestinal Polyps/drug therapy , Intestinal Polyps/metabolism , Intestinal Polyps/pathology , Mice , Mice, Knockout , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Signal Transduction/drug effects , Signal Transduction/physiology , Thyroid Hormones/metabolism , Up-Regulation/drug effects , Up-Regulation/physiology , Iodothyronine Deiodinase Type II
6.
Cell Rep ; 21(6): 1442-1451, 2017 Nov 07.
Article in English | MEDLINE | ID: mdl-29117551

ABSTRACT

Increasing evidence implies an extensive and universal interaction between the immune system and the nervous system. Previous studies showed that OCTR-1, a neuronal G-protein-coupled receptor (GPCR) analogous to human norepinephrine receptors, functions in sensory neurons to control the gene expression of both microbial killing pathways and the unfolded protein response (UPR) in Caenorhabditis elegans. Here, we found that OCTR-1-expressing neurons, ASH, are involved in controlling innate immune pathways. In contrast, another group of OCTR-1-expressing neurons, ASI, was shown to promote pathogen avoidance behavior. We also identified neuropeptide NLP-20 and AIA interneurons, which are responsible for the integration of conflicting cues and behaviors, as downstream components of the ASH/ASI neural circuit. These findings provide insights into a neuronal network involved in regulating pathogen defense mechanisms in C. elegans and might have broad implications for the strategies utilized by metazoans to balance the energy-costly immune activation and behavioral response.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Immunity, Innate , Neuropeptides/metabolism , Pseudomonas aeruginosa/pathogenicity , Sensory Receptor Cells/metabolism , Animals , Behavior, Animal , Caenorhabditis elegans/immunology , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/genetics , Microscopy, Fluorescence , Mitogen-Activated Protein Kinases/metabolism , Mutagenesis , Neuropeptides/genetics , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , p38 Mitogen-Activated Protein Kinases/metabolism
7.
Proc Natl Acad Sci U S A ; 114(37): E7697-E7706, 2017 09 12.
Article in English | MEDLINE | ID: mdl-28847964

ABSTRACT

Cancer cells alter their metabolism for the production of precursors of macromolecules. However, the control mechanisms underlying this reprogramming are poorly understood. Here we show that metabolic reprogramming of colorectal cancer is caused chiefly by aberrant MYC expression. Multiomics-based analyses of paired normal and tumor tissues from 275 patients with colorectal cancer revealed that metabolic alterations occur at the adenoma stage of carcinogenesis, in a manner not associated with specific gene mutations involved in colorectal carcinogenesis. MYC expression induced at least 215 metabolic reactions by changing the expression levels of 121 metabolic genes and 39 transporter genes. Further, MYC negatively regulated the expression of genes involved in mitochondrial biogenesis and maintenance but positively regulated genes involved in DNA and histone methylation. Knockdown of MYC in colorectal cancer cells reset the altered metabolism and suppressed cell growth. Moreover, inhibition of MYC target pyrimidine synthesis genes such as CAD, UMPS, and CTPS blocked cell growth, and thus are potential targets for colorectal cancer therapy.


Subject(s)
Adenoma/metabolism , Colorectal Neoplasms/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Adenoma/genetics , Animals , Carcinogenesis/genetics , Carcinogenesis/metabolism , Cell Proliferation/physiology , Colorectal Neoplasms/genetics , Disease Models, Animal , Female , Genes, myc , Humans , Male , Metabolomics/methods , Mice , Proto-Oncogene Proteins c-myc/genetics , Pyrimidines/biosynthesis , Transcriptome
8.
Antioxid Redox Signal ; 25(17): 953-964, 2016 12 10.
Article in English | MEDLINE | ID: mdl-27245349

ABSTRACT

AIMS: Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) is the master transcriptional regulator of antioxidant gene expression. On increased oxidative stress, an adaptor for Nrf2 degradation, Kelch-like ECH-associated protein 1 (Keap1), is directly modulated by oxidants in the cytoplasm, which results in stabilization and activation of Nrf2. Nrf2 is also constitutively active, to some extent, in the absence of exogenous oxidative stress. We have previously demonstrated that intestinal epithelium-specific TGF-ß-activated kinase 1 (TAK1) deletion downregulates the level of Nrf2 protein, resulting in an increase of reactive oxygen species (ROS) in a mouse model. We aim at determining the mechanism by which TAK1 modulates the level of Nrf2. RESULTS: We found that TAK1 upregulated serine 351 phosphorylation of an autophagic adaptor protein, p62/Sequestosome-1 (SQSTM1), which facilitates interaction between p62/SQSTM1 and Keap1 and subsequent Keap1 degradation. This, ultimately, causes increased Nrf2. Tak1 deficiency reduced the phosphorylation of p62/SQSTM1, resulting in decreased steady-state levels of Nrf2 along with increased Keap1. We also found that this regulation is independent of the canonical redox-mediated Nrf2 activation mechanism. In Tak1-deficient intestinal epithelium, a synthetic phenolic electrophile, butylated hydroxyanisole still effectively upregulated Nrf2 and reduced ROS. INNOVATION: Our results identify for the first time that TAK1 is a modulator of p62/SQSTM1-dependent Keap1 degradation and maintains the steady state-level of Nrf2. CONCLUSION: TAK1 regulates Nrf2 through modulation of Keap-p62/SQSTM1 interaction. This regulation is important for homeostatic antioxidant protection in the intestinal epithelium. Antioxid. Redox Signal. 25, 953-964.


Subject(s)
Antioxidants/metabolism , MAP Kinase Kinase Kinases/metabolism , NF-E2-Related Factor 2/metabolism , Sequestosome-1 Protein/metabolism , Animals , Cell Line , Gene Expression Regulation , Humans , Intestinal Mucosa/metabolism , Kelch-Like ECH-Associated Protein 1/metabolism , MAP Kinase Kinase Kinases/genetics , Mice , Mice, Knockout , Models, Biological , NF-E2-Related Factor 2/genetics , Oxidative Stress , Protein Binding , Proteolysis , Reactive Oxygen Species/metabolism
9.
Cancer Sci ; 106(6): 692-699, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25855137

ABSTRACT

Extracellular signal-regulated kinase is an MAPK that is most closely associated with cell proliferation, and the MEK/ERK signaling pathway is implicated in various human cancers. Although epidermal growth factor receptor, KRAS, and BRAF are considered major targets for colon cancer treatment, the precise roles of the MEK/ERK pathway, one of their major downstream effectors, during colon cancer development remain to be determined. Using Apc(Δ716) mice, a mouse model of familial adenomatous polyposis and early-stage sporadic colon cancer formation, we show that MEK/ERK signaling is activated not only in adenoma epithelial cells, but also in tumor stromal cells including fibroblasts and vascular endothelial cells. Eight-week treatment of Apc(Δ716) mice with trametinib, a small-molecule MEK inhibitor, significantly reduced the number of polyps in the large size class, accompanied by reduced angiogenesis and tumor cell proliferation. Trametinib treatment reduced the COX-2 level in Apc(Δ716) tumors in vivo and in primary culture of intestinal fibroblasts in vitro. Antibody array analysis revealed that trametinib and the COX-2 inhibitor rofecoxib both reduced the level of CCL2, a chemokine known to be essential for the growth of Apc mutant polyps, in intestinal fibroblasts in vitro. Consistently, trametinib treatment reduced the Ccl2 mRNA level in Apc(Δ716) tumors in vivo. These results suggest that MEK/ERK signaling plays key roles in intestinal adenoma formation in Apc(Δ716) mice, at least in part, through COX-2 induction in tumor stromal cells.


Subject(s)
Antineoplastic Agents/pharmacology , Cyclooxygenase 2/analysis , Genes, APC/physiology , Intestinal Polyps/drug therapy , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Protein Kinase Inhibitors/pharmacology , Pyridones/pharmacology , Pyrimidinones/pharmacology , Animals , Chemokine CCL2/analysis , Chemokine CCL2/genetics , Disease Models, Animal , Female , Intestinal Polyps/enzymology , Male , Mice
10.
Science ; 332(6030): 729-32, 2011 May 06.
Article in English | MEDLINE | ID: mdl-21474712

ABSTRACT

The unfolded protein response (UPR), which is activated when unfolded or misfolded proteins accumulate in the endoplasmic reticulum, has been implicated in the normal physiology of immune defense and in several human diseases, including diabetes, cancer, neurodegenerative disease, and inflammatory disease. In this study, we found that the nervous system controlled the activity of a noncanonical UPR pathway required for innate immunity in Caenorhabditis elegans. OCTR-1, a putative octopamine G protein-coupled catecholamine receptor (GPCR, G protein-coupled receptor), functioned in sensory neurons designated ASH and ASI to actively suppress innate immune responses by down-regulating the expression of noncanonical UPR genes pqn/abu in nonneuronal tissues. Our findings suggest a molecular mechanism by which the nervous system may sense inflammatory responses and respond by controlling stress-response pathways at the organismal level.


Subject(s)
Caenorhabditis elegans Proteins/physiology , Caenorhabditis elegans/genetics , Caenorhabditis elegans/immunology , Genes, Helminth , Immunity, Innate , Pseudomonas aeruginosa/immunology , Receptors, G-Protein-Coupled/physiology , Sensory Receptor Cells/physiology , Unfolded Protein Response/genetics , Animals , Bacterial Load , Caenorhabditis elegans/microbiology , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Down-Regulation , Endoplasmic Reticulum/metabolism , Intestinal Mucosa/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Mutation , Pharynx/metabolism , Pseudomonas aeruginosa/pathogenicity , Receptors, G-Protein-Coupled/genetics , Signal Transduction , Stress, Physiological , Transcription, Genetic , Up-Regulation
11.
J Immunol ; 185(8): 4729-37, 2010 Oct 15.
Article in English | MEDLINE | ID: mdl-20855879

ABSTRACT

The intestinal epithelium is constantly exposed to inducers of reactive oxygen species (ROS), such as commensal microorganisms. Levels of ROS are normally maintained at nontoxic levels, but dysregulation of ROS is involved in intestinal inflammatory diseases. In this article, we report that TGF-ß-activated kinase 1 (TAK1) is a key regulator of ROS in the intestinal epithelium. tak1 gene deletion in the mouse intestinal epithelium caused tissue damage involving enterocyte apoptosis, disruption of tight junctions, and inflammation. Disruption of TNF signaling, which is a major intestinal damage inducer, rescued the inflammatory conditions but not apoptosis or disruption of tight junctions in the TAK1-deficient intestinal epithelium, suggesting that TNF is not a primary inducer of the damage noted in TAK1-deficient intestinal epithelium. We found that TAK1 deficiency resulted in reduced expression of several antioxidant-responsive genes and reduced the protein level of a key antioxidant transcription factor NF-E2-related factor 2, which resulted in accumulation of ROS. Exogenous antioxidant treatment reduced apoptosis and disruption of tight junctions in the TAK1-deficient intestinal epithelium. Thus, TAK1 signaling regulates ROS through transcription factor NF-E2-related factor 2, which is important for intestinal epithelial integrity.


Subject(s)
Immunity, Mucosal/physiology , Intestinal Mucosa/enzymology , MAP Kinase Kinase Kinases/metabolism , NF-E2-Related Factor 2/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction , Animals , Blotting, Western , Epithelium/enzymology , Epithelium/immunology , Gene Expression , Gene Expression Regulation/immunology , Immunohistochemistry , Intestinal Mucosa/immunology , MAP Kinase Kinase Kinases/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , NF-E2-Related Factor 2/immunology , Oxidative Stress/immunology , Reactive Oxygen Species/immunology , Reverse Transcriptase Polymerase Chain Reaction
12.
PLoS One ; 4(2): e4561, 2009.
Article in English | MEDLINE | ID: mdl-19234607

ABSTRACT

BACKGROUND: We have previously reported that intestinal epithelium-specific TAK1 deleted mice exhibit severe inflammation and mortality at postnatal day 1 due to TNF-induced epithelial cell death. Although deletion of TNF receptor 1 (TNFR1) can largely rescue those neonatal phenotypes, mice harboring double deletion of TNF receptor 1 (TNFR1) and intestinal epithelium-specific deletion of TAK1 (TNFR1KO/TAK1(IE)KO) still occasionally show increased inflammation. This indicates that TAK1 is important for TNF-independent regulation of intestinal integrity. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we investigated the TNF-independent role of TAK1 in the intestinal epithelium. Because the inflammatory conditions were sporadically developed in the double mutant TNFR1KO/TAK1(IE)KO mice, we hypothesize that epithelial TAK1 signaling is important for preventing stress-induced barrier dysfunction. To test this hypothesis, the TNFR1KO/TAK1(IE)KO mice were subjected to acute colitis by administration of dextran sulfate sodium (DSS). We found that loss of TAK1 significantly augments DSS-induced experimental colitis. DSS induced weight loss, intestinal damages and inflammatory markers in TNFR1KO/TAK1(IE)KO mice at higher levels compared to the TNFR1KO control mice. Apoptosis was strongly induced and epithelial cell proliferation was decreased in the TAK1-deficient intestinal epithelium upon DSS exposure. These suggest that epithelial-derived TAK1 signaling is important for cytoprotection and repair against injury. Finally, we showed that TAK1 is essential for interleukin 1- and bacterial components-induced expression of cytoprotective factors such as interleukin 6 and cycloxygenase 2. CONCLUSIONS: Homeostatic cytokines and microbes-induced intestinal epithelial TAK1 signaling regulates cytoprotective factors and cell proliferation, which is pivotal for protecting the intestinal epithelium against injury.


Subject(s)
Colitis/etiology , Intestinal Mucosa/metabolism , MAP Kinase Kinase Kinases/physiology , Signal Transduction , Animals , Apoptosis , Cell Proliferation , Colitis/chemically induced , Cyclooxygenase 2 , Dextran Sulfate , Interleukin-6 , MAP Kinase Kinase Kinases/deficiency , Mice , Mice, Knockout , Receptors, Tumor Necrosis Factor, Type I/deficiency
13.
J Immunol ; 181(2): 1143-52, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18606667

ABSTRACT

Recent studies have revealed that TAK1 kinase is an essential intermediate in several innate immune signaling pathways. In this study, we investigated the role of TAK1 signaling in maintaining intestinal homeostasis by generating enterocyte-specific constitutive and inducible gene-deleted TAK1 mice. We found that enterocyte-specific constitutive TAK1-deleted mice spontaneously developed intestinal inflammation as observed by histological analysis and enhanced expression of IL-1beta, MIP-2, and IL-6 around the time of birth, which was accompanied by significant enterocyte apoptosis. When TAK1 was deleted in the intestinal epithelium of 4-wk-old mice using an inducible knockout system, enterocytes underwent apoptosis and intestinal inflammation developed within 2-3 days following the initiation of gene deletion. We found that enterocyte apoptosis and intestinal inflammation were strongly attenuated when enterocyte-specific constitutive TAK1-deleted mice were crossed to TNF receptor 1(-/-) mice. However, these mice later (>14 days) developed ileitis and colitis. Thus, TAK1 signaling in enterocytes is essential for preventing TNF-dependent epithelium apoptosis and the TNF-independent development of ileitis and colitis. We propose that aberration in TAK1 signaling might disrupt intestinal homeostasis and favor the development of inflammatory disease.


Subject(s)
Apoptosis , Colitis/immunology , Enterocytes/immunology , Ileitis/immunology , Intestinal Mucosa/immunology , MAP Kinase Kinase Kinases/metabolism , Animals , Colitis/metabolism , Enterocytes/cytology , Enterocytes/metabolism , Ileitis/metabolism , Intestinal Mucosa/metabolism , MAP Kinase Kinase Kinases/immunology , Mice , Mice, Knockout , Mice, Mutant Strains , Signal Transduction , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...